Basilea Pharmaceutica (OTCMKTS:BPMUF) Shares Gap Down – Time to Sell?

by · The Cerbat Gem

Shares of Basilea Pharmaceutica AG (OTCMKTS:BPMUF – Get Free Report) gapped down prior to trading on Wednesday . The stock had previously closed at $69.00, but opened at $60.2750. Basilea Pharmaceutica shares last traded at $60.2750, with a volume of 12 shares trading hands.

Basilea Pharmaceutica Stock Performance

The company has a current ratio of 5.11, a quick ratio of 4.68 and a debt-to-equity ratio of 0.59. The firm has a fifty day moving average price of $68.22 and a 200 day moving average price of $67.85.

About Basilea Pharmaceutica

(Get Free Report)

Basilea Pharmaceutica AG is a Swiss biopharmaceutical company headquartered in Basel, specializing in the development and commercialization of innovative treatments for hospital‐treated diseases. The company’s research is focused primarily on anti‐infectives and oncology, with a portfolio that spans both marketed products and early‐ to late‐stage pipeline candidates. Basilea leverages medicinal chemistry expertise to address critical medical needs in fungal infections, bacterial infections and cancer.

Among its lead products is isavuconazole, a broad‐spectrum antifungal agent marketed under the trade name Cresemba.

Featured Articles